Package 68788-8696-9

{"route": ["ORAL"], "spl_id": "dfb38dc3-25c5-472c-b723-c407be886316", "openfda": {"unii": ["V3888OEY5R"], "rxcui": ["897659"], "spl_set_id": ["b0eeada4-1010-4c11-b408-29f9a1af23c0"], "manufacturer_name": ["Preferred Pharmaceuticals Inc."]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET in 1 BOTTLE (68788-8696-1)", "package_ndc": "68788-8696-1", "marketing_start_date": "20240611"}, {"sample": false, "description": "30 TABLET in 1 BOTTLE (68788-8696-3)", "package_ndc": "68788-8696-3", "marketing_start_date": "20240611"}, {"sample": false, "description": "90 TABLET in 1 BOTTLE (68788-8696-9)", "package_ndc": "68788-8696-9", "marketing_start_date": "20240611"}], "brand_name": "VERAPAMIL HYDROCHLORIDE", "product_id": "68788-8696_dfb38dc3-25c5-472c-b723-c407be886316", "dosage_form": "TABLET", "pharm_class": ["Calcium Channel Antagonists [MoA]", "Calcium Channel Blocker [EPC]", "Cytochrome P450 3A Inhibitors [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]", "P-Glycoprotein Inhibitors [MoA]"], "product_ndc": "68788-8696", "generic_name": "VERAPAMIL HYDROCHLORIDE", "labeler_name": "Preferred Pharmaceuticals Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "VERAPAMIL HYDROCHLORIDE", "active_ingredients": [{"name": "VERAPAMIL HYDROCHLORIDE", "strength": "120 mg/1"}], "application_number": "ANDA206173", "marketing_category": "ANDA", "marketing_start_date": "20240611", "listing_expiration_date": "20261231"}